BIHIMA Reports Strong Q1 2026 Hearing Aid Sales
BIHIMA data for Q1 2026 shows increases in ROI sales and UK private sales compared to Q4 2025, with a notable rise in NHS adoption of rechargeable devices.
BIHIMA data for Q1 2026 shows increases in ROI sales and UK private sales compared to Q4 2025, with a notable rise in NHS adoption of rechargeable devices.
Practice owners across different healthcare specialties share how they have expanded their offerings in ways that feel natural, not transactional.
A University of Michigan researcher has developed 3D-printed acoustic tiles that can be customized to control sound reflection and enhance communication.
If approved, Regeneron's Otarmeni will be the first gene therapy for OTOF-related hearing loss in the European Union.
The company’s OtoKiosk digital audiometer and Amplifon App were recognized by the UX Design Awards and iF Design Awards for user experience and innovation.
The three-day event will focus on artificial intelligence, emerging technology, and evolving models of patient care.